-
-
-
-
-
-
-
Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting
-
-
-
-
-
-
-
Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIRâ„¢ Commercial Launch
-
-
-
-
-
-
-
Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
-
-
-
-
-
-
-
Citius Oncology Announces Closing of $9.0 Million Public Offering
-
-
-
-
-
-
-
Citius Oncology (CTOR) Anticipates Commercial Launch of LYMPHIR in 2025
-
-
-
-
-
-
-
Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

